Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIa open-label study of silarvirovir potassium plus sofosbuvir in genotype 2/3/6 chronic hepatitis C without cirrhosis
CTR20190786Phase 2Completed
- Sponsor
- Ginkgotree Pharmaceuticals
- Start
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of silarvirovir in hepatitis C virus infection, sponsored by Ginkgotree Pharmaceuticals. Started May 2019; status: completed.
02
Drugs
silarvirovir
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on CTR20190786.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20190786.